UroAlert - GU Oncology Weekly
May 21, 2020
Videos
Videos by Leading Experts
The Impact of COVID-19 on The Delivery of GU Cancer Treatment - Neeraj Agarwal
Neeraj Agarwal
Recorded: April 29, 2020Neeraj Agarwal joins Alicia Morgans to discuss the COVID-19 pandemic and its impacts on his practice in Salt Lake City, Utah.
View
Cognitive Function in Men with Prostate Cancer - Claire Pernar
Alicia Morgans invites Claire Pernar to highlight her efforts on the topic of cognitive function in men with prostate cancer.
View
Articles
Editor Selected Abstracts and Commentaries
Bladder Cancer
How reliable are imaging techniques in aging males with bladder cancer?
Robot-assisted intracorporeal orthotopic bladder substitution after radical cystectomy: perioperative morbidity and oncological outcomes - a single institution experience.
PD-1 topographically defines distinct T cell subpopulations in urothelial cell carcinoma of the bladder and predicts patient survival.
CD40 is Positively Correlated with the Expression of Nucleophosmin in Cisplatin-Resistant Bladder Cancer.
The cost effectiveness of pembrolizumab versus chemotherapy or atezolizumab as second-line therapy for advanced urothelial carcinoma in the United States.
Reframing financial incentives around reducing readmission after radical cystectomy.
UroGen Pharma Announces First Presentation of Data from Phase 2b Study of UGN-102 in Patients with Difficult to Treat Type of Bladder Cancer
The Bladder Cancer Advocacy Network Announces Awardees of Its 2020 New Discoveries Young Investigator Awards
The Khorana score for prediction of venous thromboembolism in cancer patients: an individual patient data meta-analysis.
Genetic risk scores based on risk-associated single nucleotide polymorphisms can reveal inherited risk of bladder cancer in Chinese population.
Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylation.
Transperitoneal uretercutaneostomy with use of mesosigmoid colon peritoneum in patients with bladder cancer after radical cystectomy.
Internal Audit of an Enhanced Recovery after Surgery Protocol for Radical Cystectomy - Beyond the Abstract
Percutaneous Nephrostomy in Obstructing Pelvic Malignancy Does Not Facilitate Further Oncological Treatment - Beyond the Abstract
Penile & Urethral Cancers
An overview of the diagnoses and treatments for penile cancer.
Trends in treatment of cT1 penile cancer: Analysis of the National Cancer Database.
Renal Cancer
Outcomes and predictors of benign histology in patients undergoing robotic partial or radical nephrectomy for renal masses: a multicenter study.
Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study.
CRISPR-mediated ablation of overexpressed EGFR in combination with sunitinib significantly suppresses renal cell carcinoma proliferation.
Detection of Circulating Tumor Cells in Renal Cell Carcinoma: Disease Stage Correlation and Molecular Characterization.
Single-Cell Transcriptome Analysis Reveals Intratumoral Heterogeneity in ccRCC, which Results in Different Clinical Outcomes.
Challenges of early renal cancer detection: symptom patterns and incidental diagnosis rate in a multicentre prospective UK cohort of patients presenting with suspected renal cancer.
Eligibility Criteria and Endpoints in Metastatic Renal Cell Carcinoma Trials.
A Comparison of the Predictive Role of the Geriatric Nutritional Risk Index and Immunonutritional Parameters for Postoperative Complications in Elderly Patients with Renal Cell Carcinoma.
Gender-Related Approach to Kidney Cancer Management: Moving Forward.
Histone-dependent PARP-1 inhibitors: A novel therapeutic modality for the treatment of prostate and renal cancers.
Papillary Renal Neoplasm With Reverse Polarity: A Clinicopathologic Study of 7 Cases.
An evaluation of avelumab for the treatment of genitourinary tumors.
Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG).
Clinicopathological Significance of MTUS1 Expression in Patients With Renal Cell Carcinoma.
Differentiation of renal cell carcinoma subtypes through MRI-based radiomics analysis.
Immune checkpoint inhibitors in genitourinary malignancies.
Prostate Cancer
Foundation Medicine Receives FDA Approval for FoundationOne®CDx as the Companion Diagnostic for Olaparib to Identify Patients with HRR-Mutated Metastatic Castration-Resistant Prostate Cancer
Olaparib Approved in the US for HRR Gene-Mutated Metastatic Castration-Resistant Prostate Cancer
Myriad Receives FDA Approval of BRACAnalysis CDx® as a Companion Diagnostic for Lynparza® in HRR-mutated Metastatic Castration-Resistant Prostate Cancer
Blue Earth Diagnostics Announces Results from Early Clinical Experience with Targeted PET Imaging Agent rhPSMA-7.3 (18F) in Men with Intermediate and High-risk Prostate Cancer
Quality comparison between three-dimensional T2-weighted SPACE and two-dimensional T2-weighted turbo spin echo magnetic resonance images for the brachytherapy planning evaluation of prostate and periprostatic anatomy.
Cost-Effectiveness Analysis of Prostate-Specific Antigen Screening Among Chinese Men.
Bicalutamide Elicits Renal Damage by Causing Mitochondrial Dysfunction via ROS Damage and Upregulation of HIF-1.
PSMA Expression in the Neovasculature Associated With Rectal Adenocarcinoma: A Potential Stromal Target for Nuclear Theranostics.
Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancer.
A novel immunocompetent model of metastatic prostate cancer-induced bone pain.
18F-choline PET/computed tomography and clinical parameters in the detection of significant prostate cancer in patients with increased prostate-specific antigen levels and previous negative biopsies.
Focal 18F-NaF PET Prostate Activity in the Setting of Prostate Adenocarcinoma.
Clinical outcome of PSMA-guided radiotherapy for patients with oligorecurrent prostate cancer.
Treatment in hormone-sensitive metastatic prostate cancer: factors to consider when personalizing therapy.
Estrogen receptor β exerts tumor suppressive effects in prostate cancer through repression of androgen receptor activity.
Digital frozen section of the prostate surface during radical prostatectomy: a novel approach to evaluate surgical margins.
The Diagnostic Performance of the Length of Tumor Capsular Contact on MRI for Detecting Prostate Cancer Extraprostatic Extension: A Systematic Review and Meta-Analysis.
Overweight and obesity in men with prostate cancer do not constitute risk factors for biochemical recurrence.
Androgen receptor variants: RNA-based mechanisms and therapeutic targets.
Recent Advances in the Management of High-Risk Localized Prostate Cancer: Local Therapy, Systemic Therapy, and Biomarkers to Guide Treatment Decisions.
Signaling through estrogen receptors modulates long non-coding RNAs in prostate cancer.
A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry.
Radical Prostatectomy Without Pelvic Lymph Node Dissection Is Widely Practiced in High-Risk Patients Despite Poorer Survival.
The impact of surgical margin status on prostate cancer-specific mortality after radical prostatectomy: a systematic review and meta-analysis.
Cranberry capsules are not superior to placebo capsules in managing acute non-haemorrhagic radiation cystitis in prostate cancer patients: a phase III double blinded randomised placebo controlled clinical trial.
Standard versus hypofractionated intensity-modulated radiotherapy for prostate cancer: assessing the impact on dose modulation and normal tissue effects when using patient-specific cancer biology.
Testosterone replacement therapy (TRT) and prostate cancer: An updated systematic review with a focus on previous or active localized prostate cancer.
FDA Approves First PARP Inhibitor Rucaparib for Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) and a Deleterious BRCA Mutation
Spatial patterns in prostate Cancer-specific mortality in Pennsylvania using Pennsylvania Cancer registry data, 2004-2014.
Use of genetic variation to separate the effects of early and later life adiposity on disease risk: mendelian randomisation study.
Combination immunotherapy induces distinct T-cell repertoire responses when administered to patients with different malignancies.
Somatic tissue engineering in mouse models reveals an actionable role for WNT pathway alterations in prostate cancer metastasis.
Identifying Ashkenazi Jewish BRCA1/2 founder variants in individuals who do not self-report Jewish ancestry.
Progress in applications of 18F-fluciclovine in diagnosis of prostate cancer.
Upper Tract Tumors
Interethnic Differences in the Impact of Body Mass Index on Upper Tract Urothelial Carcinoma Following Radical Nephroureterectomy - Beyond the Abstract
[Analysis of the impact on the overall survival of laparoscopic Vs open nephroureterectomy in locally advanced upper tract urinary tumors (pT3-pT4).]
CT Findings of Upper Urinary Tract Lesions in IgG4-Related Disease: Comparison With Urothelial Carcinoma.
PD-L1 Testing for Urothelial Carcinoma: Interchangeability, Reliability and Future Perspectives.
CK14 Expression Identifies a Basal/Squamous-Like Type of Papillary Non-Muscle-Invasive Upper Tract Urothelial Carcinoma.
Loss of Mismatch-repair Protein Expression and Microsatellite Instability in Upper Tract Urothelial Carcinoma and Clinicopathologic Implications.
Testicular Cancer
Venous Thromboembolism During Chemotherapy for Testicular Cancer: A Population-Based Study.
Incident testicular cancer in relation to using marijuana and smoking tobacco: A systematic review and meta-analysis of epidemiologic studies.
COVID-19 and Genitourinary Cancers
Impact of COVID-19 pandemic on the urologic practice in the emergency departments in Italy.
Androgen sensitivity gateway to COVID-19 disease severity.
Clinical Guidance for the Management of Patients with Urothelial Cancers During the COVID-19 Pandemic - Rapid Review.
Caring for older patients with cancer during the COVID-19 pandemic: A Young International Society of Geriatric Oncology (SIOG) global perspective.
The Era of COVID-19 and the Rise of Science Collectivism in Cancer Research.
Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy).
Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 (COVID-19) at a Tertiary Care Medical Center in New York City.
The management of patients with metastatic prostate cancer during the COVID-19 pandemic.
Patients With Cancer and COVID-19: A WhatsApp Messenger-Based Survey of Patients' Queries, Needs, Fears, and Actions Taken.
[Quarantine Alone or in Combination with Other Public Health Measures to Control COVID-19: A Rapid Review (Review)].
COVID-19 and Cancer: a Comprehensive Review.
Global efforts on vaccines for COVID-19: Since, sooner or later, we all will catch the coronavirus.
CONNECT WITH US
Questions or Comments? Email us at
Digital Science Press, Inc.
548 Market Street #41552
San Francisco, CA 94104-5401
You are receiving this email because you have chosen to receive emails from UroToday.
Add us to your address book
View this email as a web page
Forward to a colleague
Manage your subscriptions
Unsubscribe
Copyright ©2020 Digital Science Press, Inc.
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free
